{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:58:18Z","timestamp":1789469898810,"version":"build-2803163510"},"reference-count":117,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s11010-025-05243-w","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T11:08:29Z","timestamp":1741086509000},"page":"3951-3969","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Chloride channels and mast cell function: pioneering new frontiers in IBD therapy"],"prefix":"10.1007","volume":"480","author":[{"given":"Ahmed M.","family":"Aljameeli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bader","family":"Alsuwayt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Bharati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishnavi","family":"Gohri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Popat","family":"Mohite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudarshan","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Chidrawar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"issue":"1","key":"5243_CR1","first-page":"4810258","volume":"2017","author":"Q Guan","year":"2017","unstructured":"Guan Q, Zhang J (2017) Recent advances: the imbalance of cytokines in the pathogenesis of inflammatory bowel disease. Mediators Inflamm 2017(1):4810258","journal-title":"Mediators Inflamm"},{"issue":"1","key":"5243_CR2","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.yexcr.2017.01.024","volume":"352","author":"PK Nighot","year":"2017","unstructured":"Nighot PK, Leung L, Ma TY (2017) Chloride channel ClC-2 enhances intestinal epithelial tight junction barrier function via regulation of caveolin-1 and caveolar trafficking of occludin. Exp Cell Res 352(1):113\u2013122","journal-title":"Exp Cell Res"},{"key":"5243_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15030811","author":"YS Park","year":"2023","unstructured":"Park YS et al (2023) The ClC-2 chloride channel activator, lubiprostone, improves intestinal barrier function in biopsies from Crohn\u2019s disease but not ulcerative colitis patients. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics15030811","journal-title":"Pharmaceutics"},{"issue":"2","key":"5243_CR4","doi-asserted-by":"publisher","first-page":"G234","DOI":"10.1152\/ajpgi.00366.2007","volume":"295","author":"HF Bao","year":"2008","unstructured":"Bao HF et al (2008) A synthetic prostone activates apical chloride channels in A6 epithelial cells. Am J Physiol Gastrointest Liver Physiol 295(2):G234\u2013G251","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"3","key":"5243_CR5","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1053\/j.gastro.2009.05.037","volume":"137","author":"MJ Bijvelds","year":"2009","unstructured":"Bijvelds MJ et al (2009) Activation of intestinal Cl- secretion by lubiprostone requires the cystic fibrosis transmembrane conductance regulator. Gastroenterology 137(3):976\u2013985","journal-title":"Gastroenterology"},{"issue":"5","key":"5243_CR6","doi-asserted-by":"publisher","first-page":"C479","DOI":"10.1152\/ajpcell.00077.2014","volume":"307","author":"J Cuppoletti","year":"2014","unstructured":"Cuppoletti J et al (2014) Differentiation between human ClC-2 and CFTR Cl- channels with pharmacological agents. Am J Physiol Cell Physiol 307(5):C479\u2013C492","journal-title":"Am J Physiol Cell Physiol"},{"issue":"5","key":"5243_CR7","doi-asserted-by":"publisher","first-page":"C1173","DOI":"10.1152\/ajpcell.00528.2003","volume":"287","author":"J Cuppoletti","year":"2004","unstructured":"Cuppoletti J et al (2004) SPI-0211 activates T84 cell chloride transport and recombinant human ClC-2 chloride currents. Am J Physiol Cell Physiol 287(5):C1173\u2013C1183","journal-title":"Am J Physiol Cell Physiol"},{"issue":"3","key":"5243_CR8","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.bbrc.2012.08.097","volume":"426","author":"Y Norimatsu","year":"2012","unstructured":"Norimatsu Y, Moran AR, MacDonald KD (2012) Lubiprostone activates CFTR, but not ClC-2, via the prostaglandin receptor (EP(4)). Biochem Biophys Res Commun 426(3):374\u2013379","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"5243_CR9","first-page":"43","volume":"23","author":"MR Tanner","year":"2018","unstructured":"Tanner MR, Beeton C (2018) Differences in ion channel phenotype and function between humans and animal models. FBL 23(1):43\u201364","journal-title":"FBL"},{"key":"5243_CR10","volume-title":"Biochemistry, calcium channels","author":"D Cooper","year":"2024","unstructured":"Cooper D, Dimri M (2024) Biochemistry, calcium channels. StatPearls Publishing LLC, Treasure Island (FL)"},{"issue":"11","key":"5243_CR11","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1038\/s41593-024-01753-w","volume":"27","author":"N Korte","year":"2024","unstructured":"Korte N et al (2024) Inhibiting Ca2+ channels in Alzheimer\u2019s disease model mice relaxes pericytes, improves cerebral blood flow and reduces immune cell stalling and hypoxia. Nat Neurosci 27(11):2086\u20132100","journal-title":"Nat Neurosci"},{"issue":"3","key":"5243_CR12","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/j.1469-7793.1998.647bp.x","volume":"508","author":"E Marban","year":"1998","unstructured":"Marban E, Yamagishi T, Tomaselli GF (1998) Structure and function of voltage-gated sodium channels. J Physiol 508(3):647\u2013657","journal-title":"J Physiol"},{"issue":"4","key":"5243_CR13","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.bbamcr.2012.10.026","volume":"1833","author":"D Shy","year":"2013","unstructured":"Shy D, Gillet L, Abriel H (2013) Cardiac sodium channel NaV1.5 distribution in myocytes via interacting proteins: the multiple pool model. Biochim Biophys Acta Mol Cell Res 1833(4):886\u2013894","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"1","key":"5243_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cbdd.12237","volume":"83","author":"C Tian","year":"2014","unstructured":"Tian C et al (2014) Potassium channels: structures, diseases, and modulators. Chem Biol Drug Des 83(1):1\u201326","journal-title":"Chem Biol Drug Des"},{"issue":"1","key":"5243_CR15","doi-asserted-by":"publisher","first-page":"14644","DOI":"10.1038\/ncomms14644","volume":"8","author":"EY Chiang","year":"2017","unstructured":"Chiang EY et al (2017) Potassium channels Kv1.3 and KCa3.1 cooperatively and compensatorily regulate antigen-specific memory T cell functions. Nat Commun 8(1):14644","journal-title":"Nat Commun"},{"issue":"11","key":"5243_CR16","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1016\/j.bbamem.2013.08.002","volume":"1828","author":"J Payandeh","year":"2013","unstructured":"Payandeh J, Pfoh R, Pai EF (2013) The structure and regulation of magnesium selective ion channels. Biochim Biophys Acta Biomembranes 1828(11):2778\u20132792","journal-title":"Biochim Biophys Acta Biomembranes"},{"issue":"10","key":"5243_CR17","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.dld.2020.05.027","volume":"52","author":"D Pugliese","year":"2020","unstructured":"Pugliese D et al (2020) TRPM7 is overexpressed in human IBD-related and sporadic colorectal cancer and correlates with tumor grade. Dig Liver Dis 52(10):1188\u20131194","journal-title":"Dig Liver Dis"},{"key":"5243_CR18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/978-3-642-19922-6_11","volume-title":"Ion channels and their inhibitors","author":"SP Gupta","year":"2011","unstructured":"Gupta SP, Kaur PK (2011) Chloride ion channels: structure, functions, and blockers. In: Gupta SP (ed) Ion channels and their inhibitors. Springer, Heidelberg, pp 309\u2013339"},{"issue":"4","key":"5243_CR19","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1085\/jgp.201711946","volume":"150","author":"T-C Hwang","year":"2018","unstructured":"Hwang T-C et al (2018) Structural mechanisms of CFTR function and dysfunction. J Gen Physiol 150(4):539\u2013570","journal-title":"J Gen Physiol"},{"key":"5243_CR20","doi-asserted-by":"publisher","DOI":"10.20944\/preprints202204.0182.v1","author":"B Delalande","year":"2022","unstructured":"Delalande B, Tamagawa H, Matveev V (2022) Membrane potential: the enigma of ion pumps. Biochem Mol Biol. https:\/\/doi.org\/10.20944\/preprints202204.0182.v1","journal-title":"Biochem Mol Biol"},{"issue":"5","key":"5243_CR21","first-page":"367","volume":"120","author":"G Dai","year":"2023","unstructured":"Dai G (2023) Signaling by ion channels: pathways, dynamics and channelopathies. Mol Med 120(5):367\u2013373","journal-title":"Mol Med"},{"issue":"7","key":"5243_CR22","doi-asserted-by":"publisher","first-page":"321","DOI":"10.2183\/pjab.91.321","volume":"91","author":"T Wakabayashi","year":"2015","unstructured":"Wakabayashi T (2015) Mechanism of the calcium-regulation of muscle contraction\u2014In pursuit of its structural basis. Proc Jpn Acad Ser B 91(7):321\u2013350","journal-title":"Proc Jpn Acad Ser B"},{"issue":"6","key":"5243_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.461","volume":"11","author":"D Bennet","year":"2021","unstructured":"Bennet D et al (2021) Molecular and physical technologies for monitoring fluid and electrolyte imbalance: a focus on cancer population. Clin Transl Med 11(6):e461","journal-title":"Clin Transl Med"},{"issue":"6","key":"5243_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1009091","volume":"17","author":"S Langthaler","year":"2021","unstructured":"Langthaler S et al (2021) A549 in-silico 1.0: a first computational model to simulate cell cycle dependent ion current modulation in the human lung adenocarcinoma. PLOS Comput Biol 17(6):e1009091","journal-title":"PLOS Comput Biol"},{"issue":"19","key":"5243_CR25","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.1111\/bph.14792","volume":"176","author":"S Yin","year":"2019","unstructured":"Yin S et al (2019) Interactions of nanomaterials with ion channels and related mechanisms. Br J Pharmacol 176(19):3754\u20133774","journal-title":"Br J Pharmacol"},{"key":"5243_CR26","first-page":"485","volume-title":"Comprehensive physiology","author":"NR Tykocki","year":"2011","unstructured":"Tykocki NR, Boerman EM, Jackson WF (2011) Smooth muscle ion channels and regulation of vascular tone in resistance arteries and arterioles. Comprehensive physiology. Wiley, Hoboken, pp 485\u2013581"},{"key":"5243_CR27","doi-asserted-by":"publisher","first-page":"203683","DOI":"10.1016\/j.cdev.2021.203683","volume":"166","author":"B Canales Couti\u00f1o","year":"2021","unstructured":"Canales Couti\u00f1o B, Mayor R (2021) Mechanosensitive ion channels in cell migration. Cells Dev 166:203683","journal-title":"Cells Dev"},{"issue":"1","key":"5243_CR28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3748\/wjg.v20.i1.91","volume":"20","author":"Y-Z Zhang","year":"2014","unstructured":"Zhang Y-Z, Li Y-Y (2014) Inflammatory bowel disease: pathogenesis. World J Gastroenterol WJG 20(1):91","journal-title":"World J Gastroenterol WJG"},{"issue":"1","key":"5243_CR29","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jmb.2014.09.001","volume":"427","author":"P Subramanyam","year":"2015","unstructured":"Subramanyam P, Colecraft HM (2015) Ion channel engineering: perspectives and strategies. J Mol Biol 427(1):190\u2013204","journal-title":"J Mol Biol"},{"issue":"1","key":"5243_CR30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.hrthm.2009.08.005","volume":"7","author":"AS Amin","year":"2010","unstructured":"Amin AS, Tan HL, Wilde AA (2010) Cardiac ion channels in health and disease. Heart Rhythm 7(1):117\u2013126","journal-title":"Heart Rhythm"},{"key":"5243_CR31","doi-asserted-by":"publisher","first-page":"8109","DOI":"10.1007\/s00018-021-04011-5","volume":"78","author":"Z Deng","year":"2021","unstructured":"Deng Z et al (2021) Pathophysiological role of ion channels and transporters in gastrointestinal mucosal diseases. Cell Mol Life Sci 78:8109\u20138125","journal-title":"Cell Mol Life Sci"},{"key":"5243_CR32","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.3390\/cells10061521","volume":"10","author":"L Maggi","year":"2021","unstructured":"Maggi L et al (2021) Ion Channel gene mutations causing skeletal muscle disorders: pathomechanisms and opportunities for therapy. Cells 10:1521","journal-title":"Cells"},{"key":"5243_CR33","doi-asserted-by":"publisher","first-page":"376","DOI":"10.5334\/tohm.331","volume":"6","author":"V Marci\u00e1n","year":"2016","unstructured":"Marci\u00e1n V et al (2016) Cerebellar dysfunction and ataxia in patients with epilepsy: coincidence, consequence, or cause? Tremor Other Hyperkinet Mov 6:376","journal-title":"Tremor Other Hyperkinet Mov"},{"key":"5243_CR34","volume-title":"Electrolytes","author":"I Shrimanker","year":"2024","unstructured":"Shrimanker I, Bhattarai S (2024) Electrolytes. StatPearls Publishing, Treasure Island (FL)"},{"key":"5243_CR35","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.pbiomolbio.2022.11.003","volume":"177","author":"T Zhang","year":"2023","unstructured":"Zhang T et al (2023) The role of ion channels in immune-related diseases. Prog Biophys Mol Biol 177:129\u2013140","journal-title":"Prog Biophys Mol Biol"},{"key":"5243_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/membranes11110804","author":"A Lukasiak","year":"2021","unstructured":"Lukasiak A, Zajac M (2021) The distribution and role of the CFTR protein in the intracellular compartments. Membranes. https:\/\/doi.org\/10.3390\/membranes11110804","journal-title":"Membranes"},{"issue":"4","key":"5243_CR37","doi-asserted-by":"publisher","first-page":"605","DOI":"10.4103\/aian.AIAN_970_20","volume":"24","author":"K Chakravarty","year":"2021","unstructured":"Chakravarty K, Lal V, Ray S (2021) A novel mutation in the CLCN1 gene causing autosomal recessive myotonia congenita in siblings. Ann Indian Acad Neurol 24(4):605\u2013606","journal-title":"Ann Indian Acad Neurol"},{"key":"5243_CR38","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3389\/fphar.2020.00327","volume":"11","author":"D Sahbani","year":"2020","unstructured":"Sahbani D et al (2020) Functional study of novel bartter\u2019s syndrome mutations in ClC-Kb and rescue by the accessory subunit barttin toward personalized medicine. Front Pharmacol 11:327","journal-title":"Front Pharmacol"},{"key":"5243_CR39","volume-title":"Inflammatory bowel disease","author":"C McDowell","year":"2024","unstructured":"McDowell C, Farooq U, Haseeb M (2024) Inflammatory bowel disease. StatPearls Publishing LLC, Treasure Island (FL)"},{"key":"5243_CR40","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20212006","author":"CM Farinha","year":"2022","unstructured":"Farinha CM, Callebaut I (2022) Molecular mechanisms of cystic fibrosis\u2014how mutations lead to misfunction and guide therapy. Biosci Reports. https:\/\/doi.org\/10.1042\/BSR20212006"},{"key":"5243_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00151","author":"DR Poroca","year":"2017","unstructured":"Poroca DR, Pelis RM, Chappe VM (2017) ClC channels and transporters: structure, physiological functions, and implications in human chloride channelopathies. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2017.00151","journal-title":"Front Pharmacol"},{"issue":"11","key":"5243_CR42","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.3390\/cells10112844","volume":"10","author":"LS Hanssens","year":"2021","unstructured":"Hanssens LS, Duchateau J, Casimir GJ (2021) CFTR protein: not just a chloride channel? Cells 10(11):2844","journal-title":"Cells"},{"issue":"2","key":"5243_CR43","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrd2780","volume":"8","author":"AS Verkman","year":"2009","unstructured":"Verkman AS, Galietta LJV (2009) Chloride channels as drug targets. Nat Rev Drug Discov 8(2):153\u2013171","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"5243_CR44","doi-asserted-by":"publisher","first-page":"C932","DOI":"10.1152\/ajpcell.00334.2021","volume":"321","author":"AS Verkman","year":"2021","unstructured":"Verkman AS, Galietta LJV (2021) Chloride transport modulators as drug candidates. Am J Physiol Cell Physiol 321(6):C932\u2013C946","journal-title":"Am J Physiol Cell Physiol"},{"issue":"3","key":"5243_CR45","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.bbadis.2009.02.002","volume":"1792","author":"R Planells-Cases","year":"2009","unstructured":"Planells-Cases R, Jentsch TJ (2009) Chloride channelopathies. Biochim Biophys Acta Mol Basis Dis 1792(3):173\u2013189","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1","key":"5243_CR46","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41467-023-36244-2","volume":"14","author":"L Allen","year":"2023","unstructured":"Allen L et al (2023) Future therapies for cystic fibrosis. Nat Commun 14(1):693","journal-title":"Nat Commun"},{"issue":"2","key":"5243_CR47","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nri2018","volume":"7","author":"SC Bischoff","year":"2007","unstructured":"Bischoff SC (2007) Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data. Nat Rev Immunol 7(2):93\u2013104","journal-title":"Nat Rev Immunol"},{"key":"5243_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-9255-3-5","volume":"3","author":"M Eisenhut","year":"2006","unstructured":"Eisenhut M (2006) Changes in ion transport in inflammatory disease. J Inflamm 3:1\u201315","journal-title":"J Inflamm"},{"issue":"9","key":"5243_CR49","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.bbagen.2011.05.007","volume":"1810","author":"J Law","year":"2011","unstructured":"Law J et al (2011) The significance of chloride in the inhibitory action of disodium cromoglycate on immunologically-stimulated rat peritoneal mast cells. Biochim Biophys Acta General Subjects 1810(9):867\u2013874","journal-title":"Biochim Biophys Acta General Subjects"},{"issue":"1","key":"5243_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0014-2999(01)01371-1","volume":"431","author":"T Roloff","year":"2001","unstructured":"Roloff T et al (2001) Evidence against the functional involvement of outwardly rectifying Cl\u2212 channels in agonist-induced mast cell exocytosis. Eur J Pharmacol 431(1):1\u20139","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"5243_CR51","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3390\/ijms15010218","volume":"15","author":"MM Bi","year":"2014","unstructured":"Bi MM et al (2014) Chloride channelopathies of ClC-2. Int J Mol Sci 15(1):218\u2013249","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5243_CR52","doi-asserted-by":"publisher","first-page":"113","DOI":"10.5607\/en.2017.26.3.113","volume":"26","author":"S-J Oh","year":"2017","unstructured":"Oh S-J, Lee CJ (2017) Distribution and function of the Bestrophin-1 (Best1) channel in the brain. Exp Neurobiol 26(3):113\u2013121","journal-title":"Exp Neurobiol"},{"issue":"3","key":"5243_CR53","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/j.1469-7793.1998.825bp.x","volume":"508","author":"M Briel","year":"1998","unstructured":"Briel M, Greger R, Kunzelmann K (1998) Cl\u2212 transport by cystic fibrosis transmembrane conductance regulator (CFTR) contributes to the inhibition of epithelial Na+ channels (ENaCs) in Xenopus oocytes co-expressing CFTR and ENaC. J Physiol 508(3):825\u2013836","journal-title":"J Physiol"},{"issue":"2","key":"5243_CR54","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1152\/physrev.00039.2011","volume":"94","author":"N Pedemonte","year":"2014","unstructured":"Pedemonte N, Galietta LJV (2014) Structure and function of TMEM16 proteins (Anoctamins). Physiol Rev 94(2):419\u2013459","journal-title":"Physiol Rev"},{"key":"5243_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/cells10112844","author":"LS Hanssens","year":"2021","unstructured":"Hanssens LS, Duchateau J, Casimir GJ (2021) CFTR protein: not just a chloride channel? Cells. https:\/\/doi.org\/10.3390\/cells10112844","journal-title":"Cells"},{"issue":"1","key":"5243_CR56","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1152\/physrev.1999.79.1.S23","volume":"79","author":"DN Sheppard","year":"1999","unstructured":"Sheppard DN, Welsh MJ (1999) Structure and function of the CFTR chloride channel. Physiol Rev 79(1):S23\u2013S45","journal-title":"Physiol Rev"},{"issue":"5","key":"5243_CR57","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nrm.2016.29","volume":"17","author":"TJ Jentsch","year":"2016","unstructured":"Jentsch TJ (2016) VRACs and other ion channels and transporters in the regulation of cell volume and beyond. Nat Rev Mol Cell Biol 17(5):293\u2013307","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5243_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2023.1248648","author":"NP Negi","year":"2023","unstructured":"Negi NP et al (2023) The calcium connection: exploring the intricacies of calcium signaling in plant-microbe interactions. Front Plant Sci. https:\/\/doi.org\/10.3389\/fpls.2023.1248648","journal-title":"Front Plant Sci"},{"key":"5243_CR59","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/978-1-4419-9533-9_5","volume-title":"Mast cell biology: contemporary and emerging topics","author":"H-T Ma","year":"2011","unstructured":"Ma H-T, Beaven MA (2011) Regulators of Ca 2+ signaling in mast cells: potential targets for treatment of mast cell-related diseases? Mast cell biology: contemporary and emerging topics. Springer, Cham, pp 62\u201390"},{"key":"5243_CR60","volume-title":"Physiology, ligand gated chloride channel","author":"DT Clar","year":"2019","unstructured":"Clar DT, Maani CV (2019) Physiology, ligand gated chloride channel. StatPearls Publishing, Treasure Island"},{"issue":"3","key":"5243_CR61","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0959-4388(96)80112-7","volume":"6","author":"TJ Jentsch","year":"1996","unstructured":"Jentsch TJ (1996) Chloride channels: a molecular perspective. Curr Opin Neurobiol 6(3):303\u2013310","journal-title":"Curr Opin Neurobiol"},{"key":"5243_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1466491","author":"X Wang","year":"2024","unstructured":"Wang X et al (2024) Mast cells: a double-edged sword in inflammation and fibrosis. Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2024.1466491","journal-title":"Front Cell Dev Biol"},{"key":"5243_CR63","doi-asserted-by":"publisher","first-page":"1234885","DOI":"10.3389\/fphar.2023.1234885","volume":"14","author":"T Liu","year":"2023","unstructured":"Liu T et al (2023) Trends in volume-regulated anion channel (VRAC) research: visualization and bibliometric analysis from 2014 to 2022. Front Pharmacol 14:1234885","journal-title":"Front Pharmacol"},{"issue":"9","key":"5243_CR64","doi-asserted-by":"publisher","first-page":"4458","DOI":"10.4049\/jimmunol.1203420","volume":"190","author":"AL St John","year":"2013","unstructured":"St John AL, Abraham SN (2013) Innate immunity and its regulation by mast cells. J Immunol 190(9):4458\u20134463","journal-title":"J Immunol"},{"issue":"9573","key":"5243_CR65","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/S0140-6736(07)60750-8","volume":"369","author":"DC Baumgart","year":"2007","unstructured":"Baumgart DC, Carding SR (2007) Inflammatory bowel disease: cause and immunobiology. Lancet 369(9573):1627\u20131640","journal-title":"Lancet"},{"issue":"11","key":"5243_CR66","doi-asserted-by":"publisher","first-page":"E2086","DOI":"10.1073\/pnas.1613546114","volume":"114","author":"Z Bozoky","year":"2017","unstructured":"Bozoky Z et al (2017) Synergy of cAMP and calcium signaling pathways in CFTR regulation. Proc Natl Acad Sci 114(11):E2086\u2013E2095","journal-title":"Proc Natl Acad Sci"},{"key":"5243_CR67","first-page":"41","volume":"48","author":"D Cucu","year":"2011","unstructured":"Cucu D, Dima SO (2011) Ion channels involved in the inflammatory processes of the digestive system. Rom J Biochem 48:41\u201350","journal-title":"Rom J Biochem"},{"key":"5243_CR68","volume":"84","author":"G Bhinder","year":"2014","unstructured":"Bhinder G et al (2014) DNBS\/TNBS colitis models: providing insights into inflammatory bowel disease and effects of dietary fat. JoVE 84:e51297","journal-title":"JoVE"},{"issue":"2","key":"5243_CR69","doi-asserted-by":"publisher","DOI":"10.1080\/21688370.2018.1463897","volume":"6","author":"AN Anbazhagan","year":"2018","unstructured":"Anbazhagan AN et al (2018) Pathophysiology of IBD associated diarrhea. Tissue Barriers 6(2):e1463897","journal-title":"Tissue Barriers"},{"issue":"12","key":"5243_CR70","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1097\/MIB.0000000000000142","volume":"20","author":"MJ Hamilton","year":"2014","unstructured":"Hamilton MJ, Frei SM, Stevens RL (2014) The multifaceted mast cell in inflammatory bowel disease. Inflamm Bowel Dis 20(12):2364\u20132378","journal-title":"Inflamm Bowel Dis"},{"key":"5243_CR71","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.coph.2015.11.005","volume":"25","author":"G Boeckxstaens","year":"2015","unstructured":"Boeckxstaens G (2015) Mast cells and inflammatory bowel disease. Curr Opin Pharmacol 25:45\u201349","journal-title":"Curr Opin Pharmacol"},{"issue":"1","key":"5243_CR72","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1742-2094-7-37","volume":"7","author":"SE Lakhan","year":"2010","unstructured":"Lakhan SE, Kirchgessner A (2010) Neuroinflammation in inflammatory bowel disease. J Neuroinflammation 7(1):37","journal-title":"J Neuroinflammation"},{"issue":"4","key":"5243_CR73","doi-asserted-by":"publisher","DOI":"10.1080\/21688370.2015.1105906","volume":"3","author":"Y Jin","year":"2015","unstructured":"Jin Y, Blikslager AT (2015) ClC-2 regulation of intestinal barrier function: translation of basic science to therapeutic target. Tissue Barriers 3(4):e1105906","journal-title":"Tissue Barriers"},{"issue":"1","key":"5243_CR74","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1189\/jlb.71.1.54","volume":"71","author":"M Kulka","year":"2002","unstructured":"Kulka M et al (2002) Expression and functional characterization of CFTR in mast cells. J Leukoc Biol 71(1):54\u201364","journal-title":"J Leukoc Biol"},{"issue":"3","key":"5243_CR75","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00424-011-1035-1","volume":"463","author":"G Cui","year":"2012","unstructured":"Cui G et al (2012) Differential contribution of TM6 and TM12 to the pore of CFTR identified by three sulfonylurea-based blockers. Pfl\u00fcgers Arch Eur J Physiol 463(3):405\u2013418","journal-title":"Pfl\u00fcgers Arch Eur J Physiol"},{"key":"5243_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00565","author":"M Barone","year":"2018","unstructured":"Barone M et al (2018) A versatile new model of chemically induced chronic colitis using an outbred murine strain. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2018.00565","journal-title":"Front Microbiol"},{"key":"5243_CR77","first-page":"1","volume":"17","author":"M Arularasu","year":"2017","unstructured":"Arularasu M et al (2017) Structural, optical, morphological and microbial studies on SnO. Nanosci Nanotechnol 17:1\u20137","journal-title":"Nanosci Nanotechnol"},{"issue":"3","key":"5243_CR78","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00535-018-1439-1","volume":"53","author":"K Matsuoka","year":"2018","unstructured":"Matsuoka K et al (2018) Evidence-based clinical practice guidelines for inflammatory bowel disease. J Gastroenterol 53(3):305\u2013353","journal-title":"J Gastroenterol"},{"issue":"1","key":"5243_CR79","first-page":"9430942","volume":"2016","author":"J Bray","year":"2016","unstructured":"Bray J et al (2016) The challenges of living with inflammatory bowel disease: summary of a summit on patient and healthcare provider perspectives. Can J Gastroenterol Hepatol 2016(1):9430942","journal-title":"Can J Gastroenterol Hepatol"},{"key":"5243_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.00158","author":"M Strickland","year":"2019","unstructured":"Strickland M et al (2019) Relationships between ion channels, mitochondrial functions and inflammation in human aging. Front Physiol. https:\/\/doi.org\/10.3389\/fphys.2019.00158","journal-title":"Front Physiol"},{"issue":"2","key":"5243_CR81","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/S2222-1808(15)60992-6","volume":"6","author":"VR Chidrawar","year":"2016","unstructured":"Chidrawar VR (2016) Exploiting the role of various types of ion-channels against chemically induced inflammatory bowel disease in male Wistar rats. Asian Pacific J Trop Dis 6(2):90\u201399","journal-title":"Asian Pacific J Trop Dis"},{"key":"5243_CR82","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1213320","author":"KN Dileepan","year":"2023","unstructured":"Dileepan KN et al (2023) Mast cell-mediated immune regulation in health and disease. Front Med. https:\/\/doi.org\/10.3389\/fmed.2023.1213320","journal-title":"Front Med"},{"issue":"2","key":"5243_CR83","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1080\/19420862.2018.1548232","volume":"11","author":"CJ Hutchings","year":"2019","unstructured":"Hutchings CJ, Colussi P, Clark TG (2019) Ion channels as therapeutic antibody targets. MAbs 11(2):265\u2013296","journal-title":"MAbs"},{"issue":"3","key":"5243_CR84","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3748\/wjg.v10.i3.309","volume":"10","author":"S-H He","year":"2004","unstructured":"He S-H (2004) Key role of mast cells and their major secretory products in inflammatory bowel disease. World J Gastroenterol 10(3):309","journal-title":"World J Gastroenterol"},{"key":"5243_CR85","doi-asserted-by":"publisher","first-page":"1144980","DOI":"10.3389\/fphys.2023.1144980","volume":"14","author":"Z Li","year":"2023","unstructured":"Li Z et al (2023) Role of CD34 in inflammatory bowel disease. Front Physiol 14:1144980","journal-title":"Front Physiol"},{"issue":"1","key":"5243_CR86","doi-asserted-by":"publisher","first-page":"297","DOI":"10.4049\/jimmunol.155.1.297","volume":"155","author":"P Bradding","year":"1995","unstructured":"Bradding P et al (1995) Heterogeneity of human mast cells based on cytokine content. J Immunol 155(1):297\u2013307","journal-title":"J Immunol"},{"issue":"1","key":"5243_CR87","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.bbadis.2010.12.014","volume":"1822","author":"TC Theoharides","year":"2012","unstructured":"Theoharides TC et al (2012) Mast cells and inflammation. Biochim Biophys Acta Mol Basis Dis 1822(1):21\u201333","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"3","key":"5243_CR88","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3390\/cells10030697","volume":"10","author":"MM Rahman","year":"2021","unstructured":"Rahman MM et al (2021) Mast cell mediated regulation of small intestinal chloride malabsorption in SAMP1\/YitFc mouse model of spontaneous chronic ileitis. Cells 10(3):697","journal-title":"Cells"},{"key":"5243_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25184314","author":"JA Uranga","year":"2020","unstructured":"Uranga JA, Mart\u00ednez V, Abalo R (2020) Mast cell regulation and irritable bowel syndrome: effects of food components with potential nutraceutical use. Molecules. https:\/\/doi.org\/10.3390\/molecules25184314","journal-title":"Molecules"},{"key":"5243_CR90","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.718499","author":"AM Palma","year":"2021","unstructured":"Palma AM, Hanes MR, Marshall JS (2021) Mast cell modulation of B cell responses: an under-appreciated partnership in host defence. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2021.718499","journal-title":"Front Immunol"},{"key":"5243_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2021.155711","volume":"148","author":"EGA Neves","year":"2021","unstructured":"Neves EGA et al (2021) Systemic cytokines, chemokines and growth factors reveal specific and shared immunological characteristics in infectious cardiomyopathies. Cytokine 148:155711","journal-title":"Cytokine"},{"key":"5243_CR92","doi-asserted-by":"publisher","first-page":"9176","DOI":"10.3390\/ijms22179176","volume":"22","author":"I Shefler","year":"2021","unstructured":"Shefler I, Salamon P, Mekori YA (2021) Extracellular vesicles as emerging players in intercellular communication: relevance in mast cell-mediated pathophysiology. Int J Mol Sci 22:9176. https:\/\/doi.org\/10.3390\/ijms22179176","journal-title":"Int J Mol Sci"},{"issue":"2","key":"5243_CR93","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3390\/cells8020135","volume":"8","author":"M Albert-Bayo","year":"2019","unstructured":"Albert-Bayo M et al (2019) Intestinal mucosal mast cells: key modulators of barrier function and homeostasis. Cells 8(2):135","journal-title":"Cells"},{"key":"5243_CR94","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1122444","author":"Z Wang","year":"2023","unstructured":"Wang Z, Choi K (2023) Pharmacological modulation of chloride channels as a therapeutic strategy for neurological disorders. Front Physiol. https:\/\/doi.org\/10.3389\/fphys.2023.1122444","journal-title":"Front Physiol"},{"issue":"51","key":"5243_CR95","doi-asserted-by":"publisher","first-page":"32711","DOI":"10.1073\/pnas.2009977117","volume":"117","author":"AK Koster","year":"2020","unstructured":"Koster AK et al (2020) Development and validation of a potent and specific inhibitor for the CLC-2 chloride channel. Proc Natl Acad Sci 117(51):32711\u201332721","journal-title":"Proc Natl Acad Sci"},{"key":"5243_CR96","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22042028","author":"R Bonfiglio","year":"2021","unstructured":"Bonfiglio R et al (2021) Extensive histopathological characterization of inflamed bowel in the dextran sulfate sodium mouse model with emphasis on clinically relevant biomarkers and targets for drug development. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22042028","journal-title":"Int J Mol Sci"},{"issue":"6","key":"5243_CR97","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1085\/jgp.104.6.1099","volume":"104","author":"J Dietrich","year":"1994","unstructured":"Dietrich J, Lindau M (1994) Chloride channels in mast cells: block by DIDS and role in exocytosis. J Gen Physiol 104(6):1099\u20131111","journal-title":"J Gen Physiol"},{"key":"5243_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/cells11030349","author":"D Segura-Villalobos","year":"2022","unstructured":"Segura-Villalobos D et al (2022) Mast cell-tumor interactions: molecular mechanisms of recruitment, intratumoral communication and potential therapeutic targets for tumor growth. Cells. https:\/\/doi.org\/10.3390\/cells11030349","journal-title":"Cells"},{"issue":"1","key":"5243_CR99","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1038\/srep03363","volume":"3","author":"C Kewcharoenwong","year":"2013","unstructured":"Kewcharoenwong C et al (2013) Glibenclamide reduces pro-inflammatory cytokine production by neutrophils of diabetes patients in response to bacterial infection. Sci Rep 3(1):3363","journal-title":"Sci Rep"},{"issue":"2","key":"5243_CR100","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/17425247.2023.2166926","volume":"20","author":"CH Rische","year":"2023","unstructured":"Rische CH et al (2023) Drug delivery targets and strategies to address mast cell diseases. Expert Opin Drug Deliv 20(2):205\u2013222","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"5243_CR101","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12876-017-0602-0","volume":"17","author":"CL Wheat","year":"2017","unstructured":"Wheat CL et al (2017) Inflammatory bowel disease (IBD) pharmacotherapy and the risk of serious infection: a systematic review and network meta-analysis. BMC Gastroenterol 17(1):52","journal-title":"BMC Gastroenterol"},{"key":"5243_CR102","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.765474","volume":"8","author":"Z Cai","year":"2021","unstructured":"Cai Z, Wang S, Li J (2021) Treatment of inflammatory bowel disease: a comprehensive review. Front Med 8:765474","journal-title":"Front Med"},{"key":"5243_CR103","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.3390\/ijms11052056","volume":"11","author":"OO Erejuwa","year":"2010","unstructured":"Erejuwa OO et al (2010) Antioxidant protective effect of glibenclamide and metformin in combination with honey in pancreas of streptozotocin-induced diabetic rats. Int J Mol Sci 11:2056\u20132066. https:\/\/doi.org\/10.3390\/ijms11052056","journal-title":"Int J Mol Sci"},{"key":"5243_CR104","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2147\/SAR.S100998","volume":"7","author":"LR Webster","year":"2016","unstructured":"Webster LR, Camilleri M, Finn A (2016) Opioid-induced constipation: rationale for the role of norbuprenorphine in buprenorphine-treated individuals. Subst Abuse Rehabil 7:81\u201386","journal-title":"Subst Abuse Rehabil"},{"issue":"4","key":"5243_CR105","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jsps.2021.02.005","volume":"29","author":"V Chidrawar","year":"2021","unstructured":"Chidrawar V, Alsuwayt B (2021) Defining the role of CFTR channel blocker and ClC-2 activator in DNBS induced gastrointestinal inflammation. Saudi Pharm J 29(4):291\u2013304","journal-title":"Saudi Pharm J"},{"key":"5243_CR106","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.666732","volume":"12","author":"B Gierlikowska","year":"2021","unstructured":"Gierlikowska B et al (2021) Phagocytosis, degranulation and extracellular traps release by neutrophils-the current knowledge, pharmacological modulation and future prospects. Front Pharmacol 12:666732","journal-title":"Front Pharmacol"},{"issue":"5","key":"5243_CR107","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/cea.12043","volume":"43","author":"I Ashmole","year":"2013","unstructured":"Ashmole I, Bradding P (2013) Ion channels regulating mast cell biology. Clin Exp Allergy 43(5):491\u2013502","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"5243_CR108","first-page":"1635361","volume":"2016","author":"B Chukwunonso Obi","year":"2016","unstructured":"Chukwunonso Obi B et al (2016) Comparative study of the antioxidant effects of metformin, glibenclamide, and repaglinide in alloxan-induced diabetic rats. J Diabetes Res 2016(1):1635361","journal-title":"J Diabetes Res"},{"key":"5243_CR109","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/0470868678.ch8","volume-title":"Chronic obstructive pulmonary disease: pathogenesis to treatment","author":"A Mantovani","year":"2000","unstructured":"Mantovani A et al (2000) Macrophage control of inflammation: negative pathways of regulation of inflammatory cytokines. Chronic obstructive pulmonary disease: pathogenesis to treatment. Wiley, Hoboken, pp 120\u2013135"},{"issue":"1","key":"5243_CR110","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/BF02893062","volume":"20","author":"S Chavan","year":"2005","unstructured":"Chavan S et al (2005) Reduced glutathione: importance of specimen collection. Indian J Clin Biochem 20(1):150\u2013152","journal-title":"Indian J Clin Biochem"},{"key":"5243_CR111","doi-asserted-by":"publisher","DOI":"10.3390\/membranes12010038","author":"B Wilczy\u0144ski","year":"2022","unstructured":"Wilczy\u0144ski B et al (2022) The role of chloride channels in the multidrug resistance. Membranes. https:\/\/doi.org\/10.3390\/membranes12010038","journal-title":"Membranes"},{"key":"5243_CR112","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00459","author":"A Michalak","year":"2016","unstructured":"Michalak A, Mosi\u0144ska P, Fichna J (2016) Polyunsaturated fatty acids and their derivatives: therapeutic value for inflammatory, functional gastrointestinal disorders, and colorectal cancer. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2016.00459","journal-title":"Front Pharmacol"},{"issue":"24","key":"5243_CR113","doi-asserted-by":"publisher","first-page":"5283","DOI":"10.1113\/JP271256","volume":"593","author":"S Cruz-Rangel","year":"2015","unstructured":"Cruz-Rangel S et al (2015) Gating modes of calcium-activated chloride channels TMEM16A and TMEM16B. J Physiol 593(24):5283\u20135298","journal-title":"J Physiol"},{"issue":"3","key":"5243_CR114","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/cts.12610","volume":"12","author":"V Garg","year":"2019","unstructured":"Garg V et al (2019) Pharmacokinetic and drug-drug interaction profiles of the combination of tezacaftor\/ivacaftor. Clin Transl Sci 12(3):267\u2013275","journal-title":"Clin Transl Sci"},{"issue":"6","key":"5243_CR115","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1124\/mol.112.080267","volume":"82","author":"Y Norimatsu","year":"2012","unstructured":"Norimatsu Y et al (2012) Locating a plausible binding site for an open-channel blocker, GlyH-101, in the pore of the cystic fibrosis transmembrane conductance regulator. Mol Pharmacol 82(6):1042","journal-title":"Mol Pharmacol"},{"issue":"7","key":"5243_CR116","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.intimp.2008.03.006","volume":"8","author":"U Svajger","year":"2008","unstructured":"Svajger U, Vidmar A, Jeras M (2008) Niflumic acid renders dendritic cells tolerogenic and up-regulates inhibitory molecules ILT3 and ILT4. Int Immunopharmacol 8(7):997\u20131005","journal-title":"Int Immunopharmacol"},{"key":"5243_CR117","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11123229","author":"M Vebr","year":"2023","unstructured":"Vebr M et al (2023) A narrative review of cytokine networks: pathophysiological and therapeutic implications for inflammatory bowel disease pathogenesis. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines11123229","journal-title":"Biomedicines"}],"updated-by":[{"DOI":"10.1007\/s11010-026-05587-x","type":"expression_of_concern","label":"Expression of concern","source":"publisher","updated":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000}}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-025-05243-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-025-05243-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-025-05243-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:03:35Z","timestamp":1780470215000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-025-05243-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":117,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["5243"],"URL":"https:\/\/doi.org\/10.1007\/s11010-025-05243-w","relation":{"references":[{"id-type":"doi","id":"10.1042\/BSR20212006","asserted-by":"subject"}]},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,4]]},"assertion":[{"value":"30 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"ExpressionOfConcern","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An Editorial Expression of Concern to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11010-026-05587-x","URL":"https:\/\/doi.org\/10.1007\/s11010-026-05587-x","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}